All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

BACKGROUND: This multicentre, international phase II trial evaluated the efficacy and safety profile of a first-line combination of oral vinorelbine plus capecitabine for women with metastatic breast cancer (MBC). METHODS: Patients with measurable, HER2-negative disease received, as a first line in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tubiana-Mathieu, N, Bougnoux, P, Becquart, D, Chan, A, Conte, P-F, Majois, F, Espie, M, Morand, M, Vaissiere, N, Villanova, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720198/
https://www.ncbi.nlm.nih.gov/pubmed/19584872
http://dx.doi.org/10.1038/sj.bjc.6605156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720198/
https://www.ncbi.nlm.nih.gov/pubmed/19584872
http://dx.doi.org/10.1038/sj.bjc.6605156

Ejemplares similares